TQR Stock Overview
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.07 |
| 52 Week High | HK$1.89 |
| 52 Week Low | HK$1.03 |
| Beta | 0.40 |
| 1 Month Change | 0% |
| 3 Month Change | -13.01% |
| 1 Year Change | -41.53% |
| 3 Year Change | -10.83% |
| 5 Year Change | -35.11% |
| Change since IPO | 16.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| TQR | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -0.9% | -3.1% | -2.0% |
| 1Y | -41.5% | -31.9% | -0.3% |
Return vs Industry: TQR underperformed the German Pharmaceuticals industry which returned -31.9% over the past year.
Return vs Market: TQR underperformed the German Market which returned -0.3% over the past year.
Price Volatility
| TQR volatility | |
|---|---|
| TQR Average Weekly Movement | 6.5% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TQR has not had significant price volatility in the past 3 months.
Volatility Over Time: TQR's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1669 | 798 | Fei Chen | www.tongrentangcm.com |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services.
Beijing Tong Ren Tang Chinese Medicine Company Limited Fundamentals Summary
| TQR fundamental statistics | |
|---|---|
| Market cap | €910.70m |
| Earnings (TTM) | €64.75m |
| Revenue (TTM) | €182.71m |
14.1x
P/E Ratio5.0x
P/S RatioIs TQR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TQR income statement (TTM) | |
|---|---|
| Revenue | HK$1.52b |
| Cost of Revenue | HK$477.70m |
| Gross Profit | HK$1.05b |
| Other Expenses | HK$506.85m |
| Earnings | HK$540.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.65 |
| Gross Margin | 68.67% |
| Net Profit Margin | 35.44% |
| Debt/Equity Ratio | 0.008% |
How did TQR perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield51%
Payout RatioDoes TQR pay a reliable dividends?
See TQR dividend history and benchmarks| Beijing Tong Ren Tang Chinese Medicine dividend dates | |
|---|---|
| Ex Dividend Date | Jun 04 2024 |
| Dividend Pay Date | Jun 17 2024 |
| Days until Ex dividend | 41 days |
| Days until Dividend pay date | 54 days |
Does TQR pay a reliable dividends?
See TQR dividend history and benchmarks